When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ACOR - Acorda Therapeutics announces FDA approval of INBRIJA
Acorda Therapeutics Inc.
The FDA approves Acorda Therapeutics' (NASDAQ:ACOR) INBRIJA for intermittent treatment of OFF episodes in people with Parkinson’s disease treated with carbidopa/levodopa.
More news on: Acorda Therapeutics, Inc., Healthcare stocks news,